These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28131599)

  • 1. CYP2D6 polymorphisms are associated with effects of risperidone on neurocognitive performance in schizophrenia.
    Zeng L; Kang C; Yuan J; Zhang Y; Wei Y; Xu L; Zhou F; Yang J
    Schizophr Res; 2017 Oct; 188():50-51. PubMed ID: 28131599
    [No Abstract]   [Full Text] [Related]  

  • 2. Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han population.
    Xu Q; Wu X; Li M; Huang H; Minica C; Yi Z; Wang G; Shen L; Xing Q; Shi Y; He L; Qin S
    Pharmacogenomics J; 2016 Aug; 16(4):357-65. PubMed ID: 26282453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India.
    Kaur G; Gupta D; Chavan BS; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J
    Asian J Psychiatr; 2017 Oct; 29():174-182. PubMed ID: 28692863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1, ABCG2 and CYP2D6 polymorphism effects on disposition and response to long-acting risperidone.
    Ganoci L; Trkulja V; Živković M; Božina T; Šagud M; Lovrić M; Božina N
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110042. PubMed ID: 32682874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients.
    Du J; Zhang A; Wang L; Xuan J; Yu L; Che R; Li X; Gu N; Lin Z; Feng G; Xing Q; He L
    J Psychopharmacol; 2010 Jul; 24(7):1115-20. PubMed ID: 19395426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of CYP2D6 and CYP3A5 genotypes on the plasma concentrations of risperidone and 9-hydroxyrisperidone in Korean schizophrenic patients.
    Kang RH; Jung SM; Kim KA; Lee DK; Cho HK; Jung BJ; Kim YK; Kim SH; Han C; Lee MS; Park JY
    J Clin Psychopharmacol; 2009 Jun; 29(3):272-7. PubMed ID: 19440082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYP2D6 poor metabolizer status might be associated with better response to risperidone treatment.
    Almoguera B; Riveiro-Alvarez R; Lopez-Castroman J; Dorado P; Vaquero-Lorenzo C; Fernandez-Piqueras J; Llerena A; Abad-Santos F; Baca-García E; Dal-Ré R; Ayuso C;
    Pharmacogenet Genomics; 2013 Nov; 23(11):627-30. PubMed ID: 24026091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations.
    Ma L; Xiang Q; Zhao N; Hu C; Fang M; Tan Y; Chen S; Wang Z; Liu P; Sun K; Li Y; Wu F; Tian H; Fang M; Zhao X; Wang G; Cui Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110241. PubMed ID: 33400943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimization of maintenance therapy of Risperidone with CYP2D6 genetic polymorphisms through an extended translational framework-based prediction of target occupancies/clinical outcomes.
    Li HQ; Xu JY; Gao YY; Jin L
    Pharmacol Res; 2018 Nov; 137():135-147. PubMed ID: 30281999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone plasma levels, clinical response and side-effects.
    Riedel M; Schwarz MJ; Strassnig M; Spellmann I; Müller-Arends A; Weber K; Zach J; Müller N; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2005 Aug; 255(4):261-8. PubMed ID: 15565299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.
    Sacchetti E; Magri C; Minelli A; Valsecchi P; Traversa M; Calza S; Vita A; Gennarelli M
    Pharmacogenomics J; 2017 Mar; 17(2):146-154. PubMed ID: 26856250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between a polymorphism of the HTR3A gene and therapeutic response to risperidone treatment in drug-naive Chinese schizophrenia patients.
    Gu B; Wang L; Zhang AP; Ma G; Zhao XZ; Li HF; Feng GY; He L; Xing QH
    Pharmacogenet Genomics; 2008 Aug; 18(8):721-7. PubMed ID: 18622264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics analysis of serotonin receptor gene variants and clinical response to risperidone in Han Chinese schizophrenic patients.
    Zhou W; Chang W; Yan Y; Shen L; Li W; Yi Z; Qin S
    Neurosci Lett; 2018 Sep; 683():202-206. PubMed ID: 30081060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L
    J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone metabolism in relation to CYP2D6*10 allele in Korean schizophrenic patients.
    Roh HK; Kim CE; Chung WG; Park CS; Svensson JO; Bertilsson L
    Eur J Clin Pharmacol; 2001 Nov; 57(9):671-5. PubMed ID: 11791898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurocognitive functioning in schizophrenia: a trial of risperidone versus haloperidol.
    Addington J; Addington D
    Can J Psychiatry; 1997 Nov; 42(9):983. PubMed ID: 9429073
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of vitamin D receptor polymorphisms on the risk of schizophrenia and metabolic changes caused by risperidone treatment.
    Jiang P; Zhu MQ; Li HD; Liu YP; Cai HL; Zhang LM
    Psychiatry Res; 2014 Mar; 215(3):806-7. PubMed ID: 24418047
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the clinical efficacy of risperidone for untreated and treated cases of schizophrenia from various aspects.
    Himei A; Okamura T
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):556-62. PubMed ID: 16194258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients.
    Shi Y; Li M; Song C; Xu Q; Huo R; Shen L; Xing Q; Cui D; Li W; Zhao J; He L; Qin S
    Transl Psychiatry; 2017 Jul; 7(7):e1170. PubMed ID: 28696411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.